Scientists have identified sixteen potential therapeutic targets in low-grade serous ovarian cancer by studying proteins at the molecular level, with results published on August 11, 2025, in the journal Cancer Cell. The research was led by Ernst Lengyel, MD, PhD of University of Chicago, along with Matthias Mann, PhD, of the Max Planck Institute of … Continued
On April 1, 2025, the Rivkin Center for Ovarian Cancer Research officially joined forces with OCRA to expand education, support and research for the ovarian and gynecologic cancer community. Together, we are carrying forward the Rivkin mission to find a cure, honoring stories like Mary’s and working to ensure others have the chance for earlier … Continued
OCRA Rivkin Family SummeRun Raises Over $320,000 for Research More than 900 participants gathered at Seattle’s Seward Park for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $320,000 to advance innovative ovarian cancer research. Now in its 32nd year, the beloved 5K run/walk brought together survivors, families, friends, and supporters—all united in … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY26 Budget & Appropriations Update: Approaching August with Focused Advocacy As Congress advances the FY 2026 appropriations process, gynecologic cancer advocates have a key opportunity to engage. The House has delayed its markup of the Labor, Health and Human Services (Labor-HHS) Appropriations bill until after the … Continued
The 2025 OCRA Rivkin Family SummeRun brought together more than 900 participants in Seattle to raise critical funds for ovarian cancer research. KIRO-TV 7 Seattle (CBS) covered the event in a series of segments that shared its story with viewers across the region. Now in its 32nd year, the SummeRun was held on July 13 … Continued
KZJO-TV Fox 13 Seattle broadcast live all morning from the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun at Seward Park on July 13, 2025, giving viewers a first-hand look at its energy and impact. The 32nd annual event brought together more than 900 survivors, families, and supporters, and raised over $320,000 for innovative ovarian … Continued
More than 900 participants gathered at Seattle’s Seward Park on July 13, 2025, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. Now in its 32nd year, the beloved 5K run/walk brought together survivors, families, friends, and supporters—all united in the mission to end ovarian cancer. This year’s event raised more than $320,000 to … Continued
As a 16-year survivor of primary peritoneal cancer who is continuously in treatment, author Jane Rubin has advice for anyone who has recently received a cancer diagnosis. “Let yourself react — it is crummy news. But don’t stay down. Get yourself back up and live your best life.” A Life-Altering Diagnosis — and an Unshakable Response Jane exemplifies these … Continued
Stop Cuts to Education, Screening & Surveillance Programs The President’s proposed budget for Fiscal Year 2026 would eliminate the CDC’s Division of Cancer Prevention and Control (DCPC). This division supports the only federally funded education and screening programs focused on gynecologic cancers. If these cuts move forward, communities across the country will lose: These programs are … Continued
In a recent article, Mercer Island Reporter journalist Andy Nystrom looks at the history and ongoing impact of the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, the iconic annual 5K Run/Walk event that continues to play a vital role in raising funds for ovarian cancer research. Join the 2025 SummeRun in Seattle This year’s … Continued
SEATTLE, WA — July 7, 2025 — Hundreds of runners, walkers, families, and even some four-legged friends will gather at Seward Park on Sunday, July 13, 2025, for the OCRA Rivkin Family SummeRun, raising critical funds for ovarian cancer research. Now entering its fourth decade, this iconic and impactful 5K run/walk has raised over $10 … Continued
OCRA Featured in Fortune Article on Surgery That Reduces Ovarian Cancer Risk Ovarian Cancer Research Alliance’s (OCRA) leadership in raising awareness about opportunistic salpingectomy—a simple procedure that can significantly reduce the risk of ovarian cancer—is at the center of a new Fortune article. The story features a personal perspective from journalist and breast cancer survivor … Continued
Get email updates about research news, action alerts, and ways to join the fight.
